These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 36567199)

  • 81. Interplay between Copper, Phosphatidylserine, and α-Synuclein Suggests a Link between Copper Homeostasis and Synaptic Vesicle Cycling.
    Teng X; Stefaniak E; Willison KR; Ying L
    ACS Chem Neurosci; 2024 Aug; 15(15):2884-2896. PubMed ID: 39013013
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment.
    Kalsoom I; Wang Y; Li B; Wen H
    Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses.
    Jan A; Gonçalves NP; Vaegter CB; Jensen PH; Ferreira N
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361100
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease.
    Cardinale A; Calabrese V; de Iure A; Picconi B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204581
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric α-synuclein.
    Hannestad JK; Rocha S; Agnarsson B; Zhdanov VP; Wittung-Stafshede P; Höök F
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14178-14186. PubMed ID: 32513706
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ubiquilin-2 regulates pathological alpha-synuclein.
    Sandoval-Pistorius SS; Gerson JE; Liggans N; Ryou JH; Oak K; Li X; Negron-Rios KY; Fischer S; Barsh H; Crowley EV; Skinner ME; Sharkey LM; Barmada SJ; Paulson HL
    Sci Rep; 2023 Jan; 13(1):293. PubMed ID: 36609661
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
    Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Mechanisms Underlying the Propagation of α-Synuclein Seeds Derived from the Blood of Patients with α-Synucleinopathies].
    Okuzumi A; Hatano T; Hattori N
    Brain Nerve; 2024 Jun; 76(6):767-772. PubMed ID: 38853507
    [TBL] [Abstract][Full Text] [Related]  

  • 89. α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis.
    Scott D; Roy S
    J Neurosci; 2012 Jul; 32(30):10129-35. PubMed ID: 22836248
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.
    Kohl Z; Ben Abdallah N; Vogelgsang J; Tischer L; Deusser J; Amato D; Anderson S; Müller CP; Riess O; Masliah E; Nuber S; Winkler J
    Neurobiol Dis; 2016 Jan; 85():206-217. PubMed ID: 26523794
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The role of α-synuclein in exocytosis.
    Runwal GM; Edwards RH
    Exp Neurol; 2024 Mar; 373():114668. PubMed ID: 38147972
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease.
    Pan L; Li C; Meng L; Tian Y; He M; Yuan X; Zhang G; Zhang Z; Xiong J; Chen G; Zhang Z
    Brain; 2022 Oct; 145(10):3454-3471. PubMed ID: 35552614
    [TBL] [Abstract][Full Text] [Related]  

  • 93. α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons.
    Zaltieri M; Grigoletto J; Longhena F; Navarria L; Favero G; Castrezzati S; Colivicchi MA; Della Corte L; Rezzani R; Pizzi M; Benfenati F; Spillantini MG; Missale C; Spano P; Bellucci A
    J Cell Sci; 2015 Jul; 128(13):2231-43. PubMed ID: 25967550
    [TBL] [Abstract][Full Text] [Related]  

  • 94. α-Synuclein Mutation Inhibits Endocytosis at Mammalian Central Nerve Terminals.
    Xu J; Wu XS; Sheng J; Zhang Z; Yue HY; Sun L; Sgobio C; Lin X; Peng S; Jin Y; Gan L; Cai H; Wu LG
    J Neurosci; 2016 Apr; 36(16):4408-14. PubMed ID: 27098685
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.
    Xilouri M; Brekk OR; Stefanis L
    Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776
    [TBL] [Abstract][Full Text] [Related]  

  • 96. α-Synuclein seed amplification technology for Parkinson's disease and related synucleinopathies.
    Soto C
    Trends Biotechnol; 2024 Jul; 42(7):829-841. PubMed ID: 38395703
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cell Biology and Pathophysiology of α-Synuclein.
    Burré J; Sharma M; Südhof TC
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28108534
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Alpha synuclein PET imaging, a step closer to in vivo neuropathology in Parkinson's disease and related disorders.
    Matarazzo M; Obeso JA
    Neuron; 2024 Aug; 112(15):2457-2458. PubMed ID: 39116836
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Can infections trigger alpha-synucleinopathies?
    Tulisiak CT; Mercado G; Peelaerts W; Brundin L; Brundin P
    Prog Mol Biol Transl Sci; 2019; 168():299-322. PubMed ID: 31699323
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A functional role for alpha-synuclein in neuroimmune responses.
    Heiden DL; Monogue B; Ali MDH; Beckham JD
    J Neuroimmunol; 2023 Mar; 376():578047. PubMed ID: 36791583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.